JO1320B1 - phenethnolamine derivatives - Google Patents

phenethnolamine derivatives

Info

Publication number
JO1320B1
JO1320B1 JO19841320A JOP19841320A JO1320B1 JO 1320 B1 JO1320 B1 JO 1320B1 JO 19841320 A JO19841320 A JO 19841320A JO P19841320 A JOP19841320 A JO P19841320A JO 1320 B1 JO1320 B1 JO 1320B1
Authority
JO
Jordan
Prior art keywords
compounds
hydrogen
physiologically acceptable
protecting group
alkyl
Prior art date
Application number
JO19841320A
Other languages
Arabic (ar)
Inventor
فريدريك سكيد مور ايان
هنري تشارلز لورانس
فينش هاري
نايلور الين
Original Assignee
جلاكسو جروب ليمتد
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838317087A external-priority patent/GB8317087D0/en
Priority claimed from GB838329568A external-priority patent/GB8329568D0/en
Priority claimed from GB848401889A external-priority patent/GB8401889D0/en
Application filed by جلاكسو جروب ليمتد filed Critical جلاكسو جروب ليمتد
Application granted granted Critical
Publication of JO1320B1 publication Critical patent/JO1320B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Phenethanolamine derivatives are disclosed of formula wherein m is 2 to 8; n is 1 to 7 provided that m+n is 4 to 12; Ar is phenyl or phenyl substituted by one or two halogen atoms, alkyl or alkoxy groups or by an alkylenedioxy group; R1 and R2 are hydrogen or alkyl provided that the sum total of carbon atoms in R1 and R2 is not more than 4; and the physiologically acceptable salts and solvates thereof. The compounds have a selective stimulant action at beta 2-adrenoreceptors and may be used inter alia in the treatment of diseases associated with reversible airways obstructions such as asthma and chronic bronchitis. The compounds may be formulated in conventional manner as pharmaceutical compositions with physiologically acceptable carriers or excipients. The compounds may be prepared, for example by alkylation of an amine: where R3, R5 and R6 is hydrogen or a protecting group, followed by removal of any protecting group.
JO19841320A 1983-06-23 1984-05-02 phenethnolamine derivatives JO1320B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB838317087A GB8317087D0 (en) 1983-06-23 1983-06-23 Chemical compounds
GB838329568A GB8329568D0 (en) 1983-11-04 1983-11-04 Chemical compounds
GB848401889A GB8401889D0 (en) 1984-01-25 1984-01-25 Chemical compounds

Publications (1)

Publication Number Publication Date
JO1320B1 true JO1320B1 (en) 1986-11-30

Family

ID=48087287

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19841320A JO1320B1 (en) 1983-06-23 1984-05-02 phenethnolamine derivatives

Country Status (1)

Country Link
JO (1) JO1320B1 (en)

Similar Documents

Publication Publication Date Title
ES8609209A1 (en) Phenethanolamine derivatives
MY100124A (en) Dihydropyridazinones.
ES8707223A1 (en) Benzothiazole and benzothiophene derivatives.
ES8702880A1 (en) Phenethanolamine compounds
CA2036876A1 (en) Derivatives having a naphthalenic structure; process for preparing the same and pharmaceutical compositions containing them
ES2004676A6 (en) Dichloroaniline compounds useful for method of therapy or prophylaxis of a disease associated with reversible airway obstruction
AU6747687A (en) New derivatives of decahydroquinoline,their preparation process, the preparation intermediates, their use as medicaments and the compositions containing them
ES8609204A1 (en) Phenylisopropylamine derivative and its preparation.
ES8404356A1 (en) Pyrimido quinoxalines and their salts, their preparation, their use as medicaments and compositions containing them.
SE8503466D0 (en) aminophenol compounds
ES8207180A1 (en) Thienopyridinone derivatives, process for their preparation and their therapeutical use.
ES8404360A1 (en) 7-Acylamino-3-cephem-4-carboxylic acid derivatives, processes for the preparation of the same and pharmaceutical composition comprising the same.
NZ213222A (en) 2-(3,5-dialkyl-4-hydroxyphenyl)-indole derivatives and pharmaceutical compositions
ES8604218A1 (en) Benzoquinolizines.
JO1320B1 (en) phenethnolamine derivatives
JPS5724399A (en) Novel nucleoside derivative
ES8607973A1 (en) Amino-lower-alkyl-penem derivatives, process for their preparation, pharmaceutical compositions containing them and their use.
GB1451423A (en) 1-oxo-1h-6-substituted pyrimido-1,2-a-quinoline-2-carboxylic acids and derivatives thereof as antiallergy agents
ZA839620B (en) Carbamate derivatives,process for their preparation and pharmaceutical compositions containing them
EP0134112A3 (en) Pharmaceutical composition for prophylaxis or treatment of ketosis in livestock
MY102090A (en) Compounds with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom
ES8505653A1 (en) Treatment of migraine with N-alkyl-piperidinyl benzoate derivatives.
ES8400384A1 (en) Carbacyclines, process for their preparation and their use as medicines.
ES8602797A1 (en) 11-piperazinyl-5h-imidazoû2,1-cû1,4benzodiazepines, process for their preparation and intermediates and medicaments containing them
MY104048A (en) New allylaminoethylazoles.